Matthias Wirth

Robert Koch Str. 40
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer.

Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 07, 2026

Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.

Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.

Journal: Nature medicine

Published: January 29, 2026

Targeting PRMT5 Inhibitor-Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam.

Targeting PRMT5 Inhibitor-Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam.

Journal: Cancer research communications

Published: October 27, 2025

Genetic alterations of SENP6 in multiple myeloma disrupt genome and proteome stability, sensitizing to proteasome inhibition.

Genetic alterations of SENP6 in multiple myeloma disrupt genome and proteome stability, sensitizing to proteasome inhibition.

Journal: Haematologica

Published: September 04, 2025

The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma.

The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma.

Journal: MedComm

Published: June 25, 2025

Aberrant SUMOylation Restricts the Targetable Cancer Immunopeptidome.

Aberrant SUMOylation Restricts the Targetable Cancer Immunopeptidome.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 23, 2025

Author Correction: Segment Anything for Microscopy.

Author Correction: Segment Anything for Microscopy.

Journal: Nature methods

Published: June 09, 2025

Integrated real-time imaging of executioner caspase dynamics, apoptosis-induced proliferation, and immunogenic cell death using a stable fluorescent reporter platform.

Integrated real-time imaging of executioner caspase dynamics, apoptosis-induced proliferation, and immunogenic cell death using a stable fluorescent reporter platform.

Journal: Cell death discovery

Published: May 12, 2025

The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.

The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.

Journal: Molecular cancer therapeutics

Published: April 08, 2025

Pan-ERBB Inhibitors Synergize With KRAS Inhibitors in Rectal Cancer.

Pan-ERBB Inhibitors Synergize With KRAS Inhibitors in Rectal Cancer.

Journal: United European gastroenterology journal

Published: April 04, 2025

Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase α/δ and Small Ubiquitin-Like Modifier Signaling in Pancreatic Cancer.

Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase α/δ and Small Ubiquitin-Like Modifier Signaling in Pancreatic Cancer.

Journal: Gastroenterology

Published: February 19, 2025

Beyond Bonferroni: new multiple contrast tests for time-to-event data under non-proportional hazards.

Beyond Bonferroni: new multiple contrast tests for time-to-event data under non-proportional hazards.

Journal: Lifetime data analysis

Published: January 29, 2025

Showing 1-12 of 60

Last Updated: 09/26/2026